Consolidated Condensed Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Cash flows from operating activities:
Net income (loss)	$ 214,738	$ 184,778
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	120,713	111,587
Cost of real estate sales	10,508	23,058
Stock-based compensation expense	12,665	11,718
Deferred income taxes, net	131,741	114,795
Change in Fair Value of Contingent Consideration	0	(4,550)
Gain on litigation settlement	0	(16,400)
Park City litigation payment to Talisker	0	(10,000)
Other non-cash income, net	(2,847)	(3,009)
Changes in assets and liabilities:
Restricted Cash	7,078	36
Trade receivables, net	(27,973)	(7,761)
Inventories, net	4,857	5,380
Accounts payable and accrued liabilities	(4,641)	(203)
Other assets and liabilities, net	(11,412)	(14,953)
Net cash provided by operating activities	455,427	394,476
Cash flows from investing activities:
Capital expenditures	(88,307)	(85,583)
Acquisition of businesses	(20,245)	(182,500)
Other investing activities, net	880	3,274
Net cash used in investing activities	(107,672)	(264,809)
Cash flows from financing activities:
Proceeds from borrowings under Credit Facility Revolver	135,000	253,000
Payments on Credit Facility Revolver	(320,000)	(253,000)
Repayments of Term Loan	(6,250)	0
Repayments of Long-term Debt	(261)	(1,013)
Dividends paid	(74,530)	(52,778)
Payments for Repurchase of Common Stock	(53,787)	0
Other financing activities, net	4,760	5,041
Net cash used in financing activities	(315,068)	(48,750)
Effect of exchange rate changes on cash and cash equivalents	419	(109)
Net decrease in cash and cash equivalents	33,106	80,808
Cash and cash equivalents:
Beginning of period	35,459	44,406
End of period	68,565	125,214
Capital Expenditures Incurred but Not yet Paid	5,801	4,257
Non-cash capital expenditures under long-term financing	$ 0	$ 7,037